Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04463979 · ClinicalTrials.gov registry record
Perioperative Evaluation of Cerebellar Tumors
A clinical trial of Brain Tumor and Cerebellar Tumors, sponsored by Duke University.
- Active
- Registry status
- 66
- Enrollment target
- 1
- Study location
NCT04463979: Active study of Brain Tumor and Cerebellar Tumors, sponsored by Duke University.
NCT04463979 is a study of Brain Tumor and Cerebellar Tumors that is active but no longer recruiting, run by Duke University. The registered enrollment target is 66 participants, below the 281-participant average among 69 other Brain Tumor trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04463979, a study of Brain Tumor and Cerebellar Tumors, is active but no longer recruiting, sponsored by Duke University.
- ACTIVE NOT RECRUITING
- Registry status
- 66 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, cohort study to evaluate the impact of cerebellar functional topography on perioperative outcomes related to cognition and motor ataxia in patients with cerebellar tumors.
Primary Outcome
CCAS/Schmahmann syndrome scale: 120 point scale (0=most severe cognitive impairment to 120=no cognitive impairment)
Conditions Studied
Interventions
- OTHER Impact of Cerebellar Functional Topography on Cognition and Motor Ataxia
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2021-02-28 |
| Est. Completion | 2027-05-17 |
What the registry record for NCT04463979 still lists
NCT04463979 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 281-participant average among 69 other Brain Tumor trials with a reported enrollment target (77% lower).
The record links to 2 conditions, with Brain Tumor appearing as the primary indexed condition, and to 1 intervention - of which Impact of Cerebellar Functional Topography on Cognition and Motor Ataxia is the first listed.
NCT04463979 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT04463979 about?
NCT04463979 is a clinical study titled "Perioperative Evaluation of Cerebellar Tumors". This is a prospective, cohort study to evaluate the impact of cerebellar functional topography on perioperative outcomes related to cognition and motor ataxia in patients with cerebellar tumors.
What is the current status of trial NCT04463979?
This trial is currently active not recruiting. The enrollment target is 66 participants. The study started on 2021-02-28. Estimated completion is 2027-05-17.
What conditions does trial NCT04463979 study?
This clinical trial studies the following conditions: Brain Tumor, Cerebellar Tumors.
What interventions are being tested in trial NCT04463979?
The interventions under investigation include: Impact of Cerebellar Functional Topography on Cognition and Motor Ataxia (OTHER).
Who is sponsoring clinical trial NCT04463979?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04463979 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04463979's enrollment target sits among peer trials
66 25th of 69 higher than 45 of 69 other Brain Tumor trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Tumor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
RECRUITING · Phase 1
-
A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain
RECRUITING
-
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RECRUITING · Phase 1
-
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
RECRUITING · NA
-
Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
RECRUITING · Phase 1
-
Brodalumab in the Treatment of Immune-Related Adverse Events
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI